Skip to main content
Fig. 7 | Cancer Cell International

Fig. 7

From: miR-34a mimic or pre-mir-34a, which is the better option for cancer therapy? KatoIII as a model to study miRNA action in human gastric cancer cells

Fig. 7

The effect of stable transfection of pre-mir-34a on the cell proliferation. The flow cytometric assessment using CFSE labeling demonstrated that total number of KatoIII-pGFPC1-34a and KatoIII-pGFPC1- empty cells were proliferated at day1, but KatoIII-pGFPC1-34a cells multiplied slowly during the 3 days in culture. Overlay plots were displayed at the bottom

Back to article page
\